EUVIMEDEUVIMED entdecken
KorrekturMetaanalyse

Correction to: Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials

Joseph P Rindone, Chadwick K Mellen

European Journal of Clinical Pharmacology · 2026-11 · 82 (11)

DOI: 10.1007/s00228-026-04161-0 ↗

Kurz gefasst

Korrektur in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 12.10.2026. Verfasst von Joseph P Rindone und 1 weiteren Autor:innen. Beteiligte Einrichtung: Heart Failure Program, Northern Arizona VA Health Care System, 500 N Hwy 89, Prescott, AZ, 86313, USA. rindone7778@gmail.com.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Heart Failure Program, Northern Arizona VA Health Care System, 500 N Hwy 89, Prescott, AZ, 86313, USA. rindone7778@gmail.com.
  • Southern Arizona VA Health Care System, 3601 S. 6th Ave, Tucson, AZ, 85723, USA.

Zitieren

APA

Rindone, J. P., & Mellen, C. K. (2026). Correction to: Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials. European Journal of Clinical Pharmacology, 82(11). https://doi.org/10.1007/s00228-026-04161-0

Vancouver

Rindone JP, Mellen CK. Correction to: Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials. European Journal of Clinical Pharmacology. 2026;82(11). doi:10.1007/s00228-026-04161-0

BibTeX
@article{Rindone2026,
  author = {Rindone, Joseph P and Mellen, Chadwick K},
  title = {Correction to: Sacubitril/valsartan compared to equivalent/sub-equivalent dose angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in heart failure with reduced ejection fraction: a meta-analysis of randomized trials},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {11},
  doi = {10.1007/s00228-026-04161-0}
}
Kostenlos starten →